Back to MW MARSHALL WACE, LLP

MXCTMXCT
Showing 8 of 13 quarters

Position history for MWMARSHALL WACE, LLP's holdings in MAXCYTE INC

Yes. Marshall Wace holds 1,014,778 shares of MXCT (Maxcyte), worth $1.2M, as of its Q2 2026 13F filing. It increased the position from 98,912 shares in Q1 2026. Marshall Wace has held MXCT since Q1 2026, across 2 quarterly 13F filings.

Current Value

$1.2M

Current Shares

1M

Total Value Change

+$382,287

Total Shares Change

+792,184

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1M
+925.9%
$1.2M0.0%$1.23
41
2026-Q1
New
98,912
-
$69,2390.0%$0.76
29
2025-Q4
Exited
0
-100.0%
$00.0%$1.56
0
2025-Q3
Decreased
12,354
-90.5%
$19,5190.0%$1.50
0
2025-Q2
New
129,308
-
$281,8910.0%$2.20
32
2025-Q1
Exited
0
-100.0%
$00.0%$2.73
0
2024-Q4
Increased
252,333
+13.4%
$1M0.0%$4.11
28
2024-Q3
Decreased
222,594
-55.5%
$865,8910.0%$3.87
0

Other major holders of MXCT: Bank of New York Mellon Corp, BAMCO INC /NY/, D1 Capital Partners L.P., Artisan Partners Limited Partnership

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used